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Blastocystis is a genetically diverse and widespread intestinal parasite of animals 
and humans with controversial pathogenic potential. At least 9 subtypes of 
Blastocystis have been found in humans. Epidemiological studies of the relative 
distribution of the subtypes are emerging and may aid in the evaluation of the 
clinical significance of Blastocystis.  
We here present the genetic diversity of Blastocystis examined in stool samples 
from 68 patients from the Stockholm area, Sweden. Blastocystis was identified by 
light microscopy, and subtyping was performed by sequencing the 5’-end of the 
small subunit ribosomal RNA gene. Five Blastocystis subtypes were identified in 
the 63 patients whose samples were successfully subtyped: ST1 (15.9%), ST2 
(14.3%), ST3 (47.6%), ST4 (20.6%), and ST7 (1.6%). ST3 was more common in 
males compared to females (P= 0.049). 
Comparative molecular analysis of Blastocystis sequences in this study revealed 
intra-subtype variations within the identified subtypes with the exception of ST4. 
Among ST4 sequences in this study, as well as in the majority of human GenBank 
sequences, a limited genetic diversity was found compared to the other common 
subtypes (ST1, ST2 and ST3). The relative prevalence of ST4 in this study was 
comparable to the overall distribution of ST4 in European cohorts (16.5%). This 
contrasts with the sparse reports of ST4 in studies from other continents, which 
may indicate that the distribution of this subtype is geographically heterogeneous. 
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INTRODUCTION 
Blastocystis is an anaerobic unicellular eukaryote that can inhabit the intestinal 
tract of humans and many animals. It is the most commonly found non-fungal 
eukaryotic organism in human faecal samples [1-3]. The distribution of the 
parasite is worldwide and the prevalence in human faecal samples ranges from 7-
20 % in developed countries to 30-60% in rural areas in developing countries [4-
8]. Much is still unknown about Blastocystis. For instance, its life-cycle and 
pathogenic potential are still under debate [1,2,3,9,10]. Blastocystis is found in 
individuals both with and without symptoms. However, reports have been 
published of patients with gastrointestinal symptoms and Blastocystis as the only 
detected possible pathogen, and whose symptoms were relieved after successful 
treatment of Blastocystis [11-13]. Various gastrointestinal symptoms such as 
diarrhoea, abdominal pain, vomiting, constipation and flatulence have been linked 
to Blastocystis infection. As with other intestinal parasite infections, diarrhoeal 
episodes can alternate with normal defecation patterns or even constipation, 
conditions similar to chronic gastrointestinal illnesses such as irritable bowel 
syndrome (IBS). In fact, an increased prevalence of Blastocystis has been found in 
IBS patients [14-17]. Moreover, symptomatic Blastocystis infection has been 
reported to occur more often in immunocompromised adult patients than in 
controls [18] and has also been reported to be common in HIV-infected and 
immunocompromised children with gastrointestinal symptoms [11,19]. 
 
Molecular methods have shown extensive genetic variation among Blastocystis 
isolates [20,21]. A consensus approach has assigned Blastocystis isolates from 
humans, mammals and birds to one of nine subtypes, with sufficient genetic 
divergence between many of them to be classified as separate species [22]. 
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Recently four additional subtypes have been identified but only in non-human 
hosts [23, 24]. This genetic diversity has supported the hypothesis that the 
variability in symptoms in patients positive for Blastocystis could be due to 
different pathogenic potential among the subtypes [25-31].  
 
In a previous study investigating bacterial, viral and protozoan enteropathogens in 
Swedish patients with diarrhoea compared to healthy controls, Blastocystis was 
found in 4% of the patients and 9% of the controls [32] but no subtyping of 
Blastocystis was performed. We here present the first investigation of Blastocystis 




MATERIALS AND METHODS 
 
Patient samples 
Stool samples from patients in the Stockholm area were sent to the Laboratory of 
Diagnostic Parasitology of Karolinska University Hospital, Solna, Sweden, for 
routine ova and (oo)cyst examination. Notifications from clinicians on travel 
history and type of symptoms were only available in a minority of cases. Samples 
were sent fresh and Blastocystis was identified by light microscopy of iodine 
stained smears of faecal concentrates obtained by a modified formol-ether-
concentration technique (FECT), utilising ethyl-acetate instead of ether [33]. 
Seventy-two Blastocystis positive samples were collected randomly during 2008 
and the first few months of 2009. As a precautionary measure prior to DNA 
extraction all faecal samples were divided into two parts, one part was frozen 
5 
without additives, and one part with approximately 1 ml faeces fixed in 4 ml 70% 
ethanol was stored at +4 °C, the latter according to a protocol for PCR 
examination for Entamoeba in faeces by Lebbad and Svärd [34]. 
 
DNA extraction 
For each sample, DNA was extracted from approximately 200 mg stool using the 
QiaAMP DNA Stool Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions, and eluted in 200 µl buffer AE (Qiagen). Frozen 
samples were not thawed before extraction. Samples fixed in ethanol were washed 
three times in phosphate-buffered saline (PBS) before DNA extraction. 
 
PCR 
The method described by Scicluna et al. [26] was used for subtype analysis. The 
method includes a conventional PCR with the primers RD5 
(ATCGGTTTGATCCTGCCAGT) and BhRDr 
(GAGCTTTTTAACTGCAACAACG) amplifying an approximately 600 base pair 
(bp) fragment of the 1,800 bp small subunit ribosomal RNA gene (SSU-rDNA). 
This region of the SSU-rDNA has been shown to provide sufficient information 
for differentiating subtypes of Blastocystis [26]. One µl of extracted DNA was 
added to an amplification mixture of primers and BioMix™ (Bioline, London, 
UK) containing Taq DNA polymerase. The amplification profile consisted of 30 
cycles of denaturation, annealing and extension at 94 °C, 59 °C and 72 °C (1 min 
for each step), with  a final extension step of 2 min at 72 °C. Primarily, DNA 
extracted from frozen stool samples was used for the PCR. Where no PCR 
product was obtained, DNA was extracted from the ethanol fixed samples. 
Positive PCR products were purified using GeneJET™ Genomic DNA 
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Purification Kit (Fermentas, London, UK) according to the manufacturer’s 
recommendations. 
 
Sequencing and sequence analysis 
Purified PCR products were sequenced using the primer BhRDr, ABI BigDye 
sequencing kit version 3.1 (Applied Biosystems, Warrington, UK) and an ABI 
3730 sequencer. The resulting chromatograms were analysed and edited in the 
computer software Chromas version 2.33 (Technelysium Pty. Ltd., Australia). The 
sequences obtained were compared to Blastocystis sequences in GenBank by 
BLAST searches at the National Center for Biotechnology Information (NCBI) 
[35]. Subtypes were identified by determining the exact match or closest similarity 
according to the classification by Stensvold et al. [22]. Sequences were aligned 
with SSU-rDNA sequences representing ST1-9 from GenBank using the software 
ClustalW [36] and MEGA version 4 [37] for comparative analysis of the sequence 
data.  
Sequences obtained in the study are available as accession numbers JN003684-
JN003686 and JN587541-JN587549 in the GenBank database. 
 
Phylogenetic analysis of Blastocystis 
To infer phylogenetic relationships among the sequences, phylogenetic trees were 
constructed with the neighbor-joining (NJ) method [38] using the software MEGA 
version 4 [37]. The flagellate Proteromonas lacertae (accession number U37108) 
was used as the outgroup as in previous phylogenetic studies [40,41]. Bootstrap 





For comparison of subtype prevalence of different groups the χ2 test (with 
collapsed categories when needed) was used. A P-value less than 0.05 was 
considered statistically significant. The software PASW version 18 (SPSS Inc, 




Blastocystis was identified by light microscopy in 72 faecal samples from 68 
patients, 30 females and 38 males. The age of the patients ranged from 1 to 70 y, 
the median age was 30.5 y (interquartile range 16-46) in females and 38.5 y 
(interquartile range 26-49) in males. The age distribution is displayed in Fig.1. In 
63 of the 68 patients the expected 600 bp fragment of the SSU-rDNA was 
amplified and successfully sequenced. In 4 of the 68 patient samples no PCR 
product was produced despite repeated DNA extractions and numerous attempts 
towards optimising PCR conditions. In one sample a PCR product of the correct 
size was obtained but the resulting sequence chromatogram showed double peaks, 
which may indicate a mixed infection of two or more Blastocystis subtypes. 
 
Five Blastocystis subtypes were identified in the study, ST1, ST2, ST3, ST4, and 
ST7 (Fig. 2). ST3 was the most prevalent subtype, found in 30/63 patients 
(47.6%) followed by ST4 in 13/63 patients (20.6%). One patient harboured 
Blastocystis ST7, a subtype that has been found mostly in birds [42]. For 
comparison, Blastocystis subtype distributions found in previous European studies 
are displayed in Table 1. 
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There was a difference between men and women in the prevalence of ST3 and 
ST4 (Fig 3). Although supported by a marginal significance, ST3 was more 
common in males compared to females (P=0.049, collapsed categories). Among 
females ST4 was almost as common as ST3 but the difference in the relative 
frequency of ST4 among men and women was not statistically significant 
(P=0.13) (Fig. 3). 
 
As previously reported [26] the sequence variation in the 5’-end of the SSU-rRNA 
gene of Blastocystis is extensive. The isolate BL051 (accession number 
JN003686), assigned to ST7, differs from its closest match in GenBank 
(DQ232821) by 7 nucleotides in the studied region of SSU-rDNA. A4. However 
this level of divergence falls within the range of variation identified among 
previously published ST7 sequences (Fig 2). A similar level of diversity was seen 
among samples assigned to STs 1-3 identified in this study *ST1: up to2 
differences; ST2: up to 6 differences; ST3: up to 6 differences). In contrast, no 
variation was found among the thirteen identified ST4 sequences. A BLAST 
search revealed that the ST4 sequences of this study were identical to most 
published ST4 SSU-rRNA genes, among them 17 from human isolates deposited 
by Scicluna et al. [26], three human and four rat ST4 sequences from France 
[43,21] and three sequences from humans in Japan and Germany [44]. Single 
nucleotide polymorphisms (SNPs) differentiated these sequences from a group of 
five previously published ST4 sequences from rodents that all shared at least three 
of the SNPs [41,45]. The sequence diversity leads to the generation of two clades 





During the last few years several studies of the prevalence of Blastocystis 
subtypes have been published. This study is, to our knowledge, the first that 
describes the occurrence of different Blastocystis subtypes in Sweden. ST3 was 
the most common Blastocystis subtype found in the Stockholm area. The 
distribution of Blastocystis subtypes in human faecal samples varies from country 
to country. However, ST3 has dominated as the most prevalent subtype in most 
studies although the figures differ depending on populations studied [43].  
 
ST4 was the second most prevalent subtype in our study, being found in 20.6% of 
the samples. This is in contrast to an average prevalence figure of 5.4% reported 
by Souppart et al. in 2009 in a summary of Blastocystis subtypes from different 
countries [43]. In most studies ST4 was the fourth most common subtype found in 
humans, after ST3, ST1 and ST2. However, when only studies from Europe are 
included in the comparison, and with additional data from the two last years 
included, the average prevalence for ST4 increases to 16.5% (Table 1). Using this 
figure, our findings are generally in concordance with the results from the rest of 
Europe. Since very few isolates of ST4 have been identified in studies from Asia, 
among them a large study of Blastocystis prevalence in China by Li et al. [8], the 
results may also indicate geographic differences in the prevalence of ST4.  
Interestingly, studies from Turkey, a country situated both in Europe and Asia, 
also reports very low numbers of ST4 (1/337 samples) (Table 1). It should be kept 
in mind, however, that differences in study populations and methodology used 
may influence the results. 
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Blastocystis carriers in the present study were diagnosed primarily by light 
microscopy. Routine examination using FECT is considered to have a low 
sensitivity of approximately 30-50% for the detection of Blastocystis [4,46]. The 
sensitivity has been shown to be lower for ST3 compared to the other subtypes 
[46]. Our selection method could therefore have underestimated the prevalence of 
ST3. The faecal samples in the present study were all from a diagnostic 
parasitology laboratory suggesting that the majority of the samples arise from 
patients with gastrointestinal symptoms. No PCR product could be amplified in 
the samples from four of the patients in this study. Possible reasons for this could 
be PCR inhibition, degradation of DNA due to long storage time or 
misidentification by light microscopy. 
 
A difference in the occurrence of ST3 and ST4 between men and women was 
found. The higher relative frequency of ST3 in men was statistically significant, 
although the sample size in each subtype group was small. Differences in the 
relative proportions of subtypes between the sexes could indicate distinct 
pathways of transmission or exposure to the organism.  Further studies are needed 
to confirm the gender difference in the distribution of subtypes of Blastocystis.  
 
Overall the amplified fragment of Blastocystis SSU-rDNA exhibited extensive 
sequence variability. Although a limited number of Blastocystis were examined, 
variability was found within subtypes. This further supports the suggestion that 
the diversity in Blastocystis STs may qualify them to be classified as separate 
species, since the ribosomal RNA genes in most organisms are generally 
considered as too conserved to discriminate between subspecies variants. A4 The 
recent genome sequence of a Blastocystis ST7 strain [38] showed that some minor 
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sequence variation does exist among individual copies of the SSU-rRNA gene in 
the genome. However, intra-strain variation does not interfere with assignment of 
Blastocystis samples to subtypes as the sequence obtained from the PCR reaction 
represents only the dominant sequence in the sample.  The assignment of 
Blastocystis isolates to subtypes generated by the SSU-rRNA gene may be 
insufficient to clarify questions about pathogenic potential and transmission 
patterns. A further subdivision of the subtypes with molecular techniques that 
have a higher discriminatory capacity, for example multilocus sequence typing 
(MLST), will possibly aid in investigations of the epidemiology of Blastocystis 
and possible associations between subtypes and pathogenicity. Aspects of 
zoonotic potential and transmission patterns may also be revealed by better 
discrimination among the subtypes. MLST has been used in many bacterial 
species but has recently also been used for subdivision of assemblages in the 
intestinal parasitic protozoan Giardia intestinalis [48,49].  
 
An interesting observation was the low genetic variability found in the ST4 
sequences compared to what was seen among the other common subtypes 
identified in the study. In a BLAST search these Blastocystis sequences were 
identical to human ST4 sequences from different parts of the world in addition to 
four Blastocystis sequences from rodent faeces with origins in France [21]. 
Another group of rodent isolates with at least three SNPs in common constituted 
another lineage among the ST4 sequences that was revealed in the phylogenetic 
tree (Fig. 2). A similar branching among ST4 sequences has been shown by Noël 
et al. [21] when examining mostly rodent isolates, and Stensvold et al. [31]. If the 
data indicating a low variability among human ST4 sequences can be confirmed 
by examination of other genes this may indicate that the ST4 lineage has 
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expanded more recently on an evolutionary scale. In epidemiological studies a 
low grade of variability within a subgroup of isolates can also be explained by a 
selection of a specific lineage caused by advantageous properties for colonization 
or infection [50,51]. Since the epidemiological context of the sequences compared 
in this study is unknown no such conclusions can be drawn. However, in relation 
to this hypothesis it is interesting that 76% of Blastocystis positive patients with 
acute diarrhoea harboured ST4 isolates in a recently published Danish study [31], 
indicating that ST4 may have a pathogenic potential. 
 
In summary, Blastocystis of ST1, ST2, ST3, ST4, and ST7 were identified in 63 
Swedish patient faecal samples with a dominance of ST3 (47.6%), followed by 
ST4 (20.6%). Intra-subtype sequence variations were identified in all the subtypes 
with the exception of ST4, which showed low variability in the 5’-end of SSU-
rRNA. A comparison with recent studies in Europe indicates that the relative 
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Table 1. Blastocystis subtype distribution in different European countries. 
 




 Subtype distribution (%) c 
 
     
   ST1 ST2 ST3 ST4 ST5 ST6 ST7 ST8 ST9
Denmark [52] Sequencing 29  3.4 20.7 51.7 24.1 0 0 0 0 0
Denmark [46] Sequencing 28  17.9 32.1 46.4 3.6 0 0 0 0 0
Denmark [17] Sequencing 116  26.7 33.6 36.2 21.6 0 0.9 5.2 0 0.9
Denmark [4] Sequencing 99  20.2 15.2 39.4 16.2 0 1.0 0 1.0 0
Denmark [53] Sequencing 22  50.0 0 59.1 0 0 0 0 0 0
Denmark [31] Sequencing 25  4.0 16.0 4.0 76.0 0 0 0 0 0
France [43] Sequencing 40  27.5 10.0 57.5 10.0 0 0 2.5 0 0
France [54] Sequencing 27  3.7 3.7 14.8 63.0 0 3.7 11.1 0 0
Germany [55] RFLP 166  24.1 0.6 71.1 7.2 0 0 0 0 0
Germany [44] STS primers 12  25.0 16.7 41.7 16.7 0 0 0 - -
Greece [56] SSCP 45  20.0 13.3 60.0 2.2 0 2.2 2.2 0 0
Ireland [57] Sequencing 14  7.1 42.9 28.6 21.4 0 0 0 0 0
Italy [58] Sequencing 30  10.0 23.3 53.3 20.0 0 0 3.3 3.3 0
Spain [30] RFLP 51  2.0 3.9 0 94.1 0 0 0 0 0
Sweden a Sequencing 63  15.9 14.3 47.6 20.6 0 0 1.6 0 0
Turkey [28] STS primers 92  20.6 23.9 59.8 0 0 0 0 - -
Turkey [59] Sequencing 87  9.2 13.8 75.9 1.1 0 0 0 0 0
Turkey [60] STS primers 32  62.5 9.4 28.1 0 0 0 0 - -
Turkey [29] STS primers 35  8.6 37.1 62.9 0 0 0 0 - -
Turkey [61] STS primers 66  28.8 16.7 68.2 0 0 0 0 - -
Turkey [62] STS primers 25  36.0 34.0 40.0 0 0 0 0 - -
UK [20] RFLP 29  6.9 3.4 75.9 13.8 0 0 0 0 0
UK [26] Sequencing 55  5.5 16.4 40.0 31.0 0 0 0 5.5 0
Total  1188  19.4 15.8 50.6 16.5 0 0.3 1.2 0.4 0.1
 
a Present study 
b Abbreviations used: RFLP = restriction fragment length polymorphism of SSU-rRNA 
genes, STS primers = sequence-tagged site primers (specific for each subtype 1-7), SSCP 
= single strand conformational polymorphism 
c The percentages can add up to less or more than 100 in each study depending on if the 


















 Figure legends 
 
Fig 1. The age distribution of patients positive for Blastocystis by light 
microscopy. 
 
Fig 2. A phylogenetic tree comparing representative Blastocystis SSU-rDNA 
sequences generated in this study, designated ‘BL0--’, and reference sequences 
from GenBank, shown with accession numbers. The tree is inferred using the 
neighbor-joining method (with the maximum composite likelihood model) based 
on a hypervariable region at the 5’ end of the SSU-rRNA gene. Proteromonas 
lacertae (accession number U37108) is used as the outgroup. Bootstrap values 
(%) are indicated at the internal nodes (1,000 replicates). Bootstrap values of less 
than 50% are not shown. The subtype prevalence in the 63 samples is shown to 
the right as percentages. Italicised subtypes were not found in the present study. 
 
Fig 3. Distribution of Blastocystis subtypes in males and females. 
 
 
